Pharmaceutical and agricultural companies: Bayer consolidates US glyphosate business amid wave of lawsuits

Bayer is spinning off its US business with the controversial weed killer glyphosate into its own subsidiary. The new unit is intended to react more agilely to the market and lawsuits.